Key Points It is being acquired for quite a meaty premium. The buyer is a top name in the global pharmaceuticals space. 10 stocks we like better than Avidity Biosciences › A richly priced buyout seriously boosted the share price of biotech Avidity Biosciences (NASDAQ: RNA) as the stock trading week began. The company's equity rose by 42%, closing to land just below the buyout price. This leap looked quite impressive next to the S&P 500 (SNPINDEX: ^GSPC), as the bellwether stock indicator only incre ...